The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Journal: Evidence-based Cardiology. 2018;11(1): 36‑39

Read: 951 times

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

. Evidence-based Cardiology. 2018;11(1):36‑39. (In Russ.)

МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Abstract:

Close metadata

References:

  1. 1.Wilson P.W., Kannel W.B., Silbershatz H., et al. Clustering of metabolic factors and coronary heart disease. Arch Intern Med 1999;159:1104—1109.
  2. Berry J.D., Dyer A., Cai X., et al. Lifetime risks of cardiovascular disease. N Engl J Med 2012;366:321—329.
  3. Ettehad D., Emdin C.A., Kiran A., et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet 2016;387:957—967.
  4. Guo X., Zhang X., Guo L., et al. Association between pre-hypertension and cardiovascular outcomes: a systematic review and meta-analysis of prospective studies. Curr Hypertens Rep 2013;15:703—716.
  5. Guo X., Zhang X., Zheng L., et al. Prehypertension is not associated with all-cause mortality: a systematic review and meta-analysis of prospective studies. PLoS ONE 2013;8:e61796.
  6. Huang Y., Cai X., Li Y., et al. Prehypertension and the risk of stroke: a meta-analysis. Neurology 2014;82:1153—1161.
  7. Huang Y., Cai X., Liu C., et al. Prehypertension and the risk of coronary heart disease in Asian and Western populations: a meta-analysis. J Am Heart Assoc 2015;4:e001519.
  8. Huang Y., Cai X., Zhang J., et al. Prehypertension and incidence of ESRD: a systematic review and meta-analysis. Am J Kidney Dis 2014;63:76—83.
  9. Huang Y., Su L., Cai X., et al. Association of all-cause and cardiovascular mortality with prehypertension: a meta-analysis. Am Heart J 2014;167:160—168.e1.
  10. Huang Y., Wang S., Cai X., et al. Prehypertension and incidence of cardiovascular disease: a meta-analysis. BMCMed 2013;11:177.
  11. Law M.R., Morris J.K., Wald N.J. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009;338:b1665.
  12. Lee M., Saver J.L., ChangB., et al. Presence of baseline prehypertension and risk of incident stroke: a meta-analysis. Neurology 2011;77:1330—1337.
  13. Shen L., MaH., Xiang M.-X., et al. Meta-analysis of cohort studies of baseline prehypertension and risk of coronary heart disease. Am J Cardiol 2013;112:266—271.
  14. Sundstrom J., Arima H., Jackson R., et al. Effects of blood pressure reduction in mild hypertension: a systematic review and meta-analysis. Ann Intern Med 2015;162:184—191.
  15. Thomopoulos C., Parati G., Zanchetti A. Effects of blood pressure lowering on outcome incidence in hypertension: 2. Effects at different baseline and achieved blood pressure levels — overview and meta-analyses of randomized trials. J Hypertens 2014;32:2296—2304.
  16. Wang S., Wu H., Zhang Q., et al. Impact of baseline prehypertension on cardiovascular events and all-cause mortality in the general population: a meta-analysis of prospective cohort studies. Int J Cardiol 2013;168:4857—4860.
  17. XieX., Atkins E., Lv J., et al. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis. Lancet 2016;387:435—443.
  18. Cushman W.C., Ford C.E., Cutler J.A., et al. Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). J Clin Hypertens (Greenwich) 2002;4:393—404.
  19. Dahlof B., Devereux R.B., Kjeldsen S.E., et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002;359:995—1003.
  20. Wald D.S., Law M., Morris J.K., et al. Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials. Am J Med 2009;122:290—300.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.